Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study

被引:13
|
作者
Prabhakar, Tushar [1 ]
Kaushal, Kanica [1 ]
Prasad, Manya [1 ]
Gupta, Ekta [2 ]
Sood, Ajit [3 ]
Jain, Ajay K. [4 ]
Shukla, Akash [5 ]
Goel, Ashish [6 ]
Duseja, Ajay [7 ]
Saraya, Anoop [8 ]
Shah, Samir [9 ]
Kumar, Guresh [10 ]
Sarin, Shiv Kumar [11 ]
机构
[1] Inst Liver & Biliary Sci, Dept Clin Epidemiol, New Delhi, India
[2] Inst Liver & Biliary Sci, Dept Virol, New Delhi, India
[3] Dayanand Med Coll & Hosp, Dept Gastroenterol, Ludhiana, India
[4] Choithram Hosp & Res Ctr, Dept Gastroenterol, Indore, India
[5] GS Med Coll & KEM Hosp, Dept Gastroenterol, Mumbai, India
[6] Christian Med Coll & Hosp, Dept Hepatol, Vellore, India
[7] Postgrad Inst Med Educ & Res, Dept Hepatol, Chandigarh, India
[8] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India
[9] Global Hosp, Dept Transplant Hepatol, HPB, Liver Intens Care, Mumbai, India
[10] Inst Liver & Biliary Sci, Dept Biostat, New Delhi, India
[11] Inst Liver & Biliary Sci, Dept Hepatol, New Delhi, India
关键词
Cirrhosis; HCC; Cirrhotic HCC; Non-cirrhotic HCC; Epidemiology; India; Chronic liver disease; Liver cancer; NAFLD; Risk factor; FATTY LIVER-DISEASE; RISK-FACTORS; NONCIRRHOTIC LIVER; PROFILE; HEPATOCARCINOGENESIS; EPIDEMIOLOGY; PATHOGENESIS; NAFLD; HCC;
D O I
10.1007/s12072-023-10498-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundHepatocellular cancer (HCC) typically arises in the background of cirrhosis. The epidemiology of HCC has changed in recent years due to availability of newer antivirals, changing life-styles and greater possibility for early detection. We undertook a multicentric national sentinel surveillance for liver cirrhosis and HCC to assess the attributable risk factors for the development of HCC, both with and without a background of cirrhosis.MethodsData from January 2017 till August 2022 from hospital-based records of eleven participating centers were included. Diagnosed cases of cirrhosis [radiological (multiphase and/or histopathological] and HCC [as per AASLD 2018] were included. History of significant alcohol intake was elicited by AUDIT-C questionnaire.ResultsAltogether 5798 enrolled patients were assessed, of which 2664 patients had HCC. The mean age was 58.2 +/- 11.7 years and 84.3% (n = 2247) were males. Diabetes was found in over a third of those with HCC (n = 1032;39.5%). The most common etiology of HCC was NAFLD (n = 927;35.5%) followed by viral hepatitis B and C and harmful levels of alcohol. Among those with HCC, 27.9% (n = 744) had no cirrhosis. Higher proportion of cirrhotic HCC patients had alcohol as an etiological factor as compared to non-cirrhotic (17.5 vs. 4.7%, p <= 0.001). NAFLD was an etiological factor for a higher proportion of non-cirrhotic HCC patients as compared to cirrhotic HCC (48.2 vs. 30.6%, p <= 0.001). Diabetics more commonly had non-cirrhotic HCC (50.5 vs. 35.2%). The following factors were associated with an occurrence of cirrhotic HCC: male gender (OR 1.372 and 95% CI 1.070-1.759), age above 60 years (OR 1.409 and 95% CI 1.176-1.689), HBV (OR 1.164 and 95% CI 0.928-1.460), HCV (OR 1.228 and 95 CI 0.964-1.565) and harmful consumption of alcohol (OR 3.472 and 95% CI 2.388-5.047). The adjusted odds of non-cirrhotic patients having NAFLD was 1.553 (95% CI 1.290-1.869).ConclusionThis large multi-centric study demonstrates that NAFLD is the most important risk factor for development of both cirrhotic and non-cirrhotic HCC in India and has overtaken viral hepatitis. Awareness campaigns and large-scale screening are required to reduce the high burden of NAFLD-related HCC in India.
引用
收藏
页码:745 / 752
页数:8
相关论文
共 50 条
  • [1] Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study
    Tushar Prabhakar
    Kanica Kaushal
    Manya Prasad
    Ekta Gupta
    Ajit Sood
    Ajay K. Jain
    Akash Shukla
    Ashish Goel
    Ajay Duseja
    Anoop Saraya
    Samir Shah
    Guresh Kumar
    Shiv Kumar Sarin
    Hepatology International, 2023, 17 : 745 - 752
  • [2] Convergent Evolution of Copy Number Alterations in Multi-Centric Hepatocellular Carcinoma
    Lackner, Carolin
    Quagliata, Luca
    Cross, William
    Ribi, Sebastian
    Heinimann, Karl
    Paradiso, Viola
    Quintavalle, Cristina
    Kovacova, Monika
    Baumhoer, Daniel
    Piscuoglio, Salvatore
    Terracciano, Luigi
    Kovac, Michal
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [3] Convergent Evolution of Copy Number Alterations in Multi-Centric Hepatocellular Carcinoma
    Carolin Lackner
    Luca Quagliata
    William Cross
    Sebastian Ribi
    Karl Heinimann
    Viola Paradiso
    Cristina Quintavalle
    Monika Kovacova
    Daniel Baumhoer
    Salvatore Piscuoglio
    Luigi Terracciano
    Michal Kovac
    Scientific Reports, 9
  • [4] A Multi-centric retrospective study into the epidemiological distribution of breast cancer patients in India
    Reddy, Vijay Anand
    Sarin, Ramesh
    Panda, Dipanjan
    Hanitha, Rnm
    Jain, Jugnu
    Chatterjee, Soma
    Annapurneswari, S.
    Saipillai, Mohamed Zehran
    Gupta, Shaikat
    Khan, Enamuddin
    Bhattacharya, Jibak
    Bhandari, Trilok Prasad Singh
    Prasad, S. V. S. S.
    Swain, Meenakshi
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 2) : S869 - S876
  • [5] A Multi-centric retrospective study into the epidemiological distribution of breast cancer patients in India
    Reddy, Vijay Anand
    Sarin, Ramesh
    Panda, Dipanjan
    Hanitha, R. N. M.
    Jain, Jugnu
    Chatterjee, Soma
    Annapurneswari, S.
    Saipillai, Mohamed Zehran
    Gupta, Shaikat
    Khan, Enamuddin
    Bhattacharya, Jibak
    Bhandari, Trilok Prasad Singh
    Prasad, S. V. S. S.
    Swain, Meenakshi
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 : S869 - S876
  • [6] Real-world data of nivolumab in advanced hepatocellular carcinoma: A multi-centric and retrospective study
    Sardinha, M.
    Simao, D.
    Reis, A.
    Spencer, A.
    Parmanande, A.
    Saraiva, R.
    Calinas, F.
    Filipe, F.
    Winckler, P.
    da Luz, R.
    Martins, M.
    Gramaca, J.
    Ramos, M.
    Cadavez, E.
    Moura, M.
    Gil, L.
    Presa, J.
    Carrola, P.
    Pinho, I.
    Carvalho, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S127 - S127
  • [7] Primary carcinoma of the liver of possible multi-centric origin occurring in a case of portal cirrhosis
    McIndoe, AH
    Counseller, VS
    AMERICAN JOURNAL OF PATHOLOGY, 1926, 2 (03): : 557 - 564
  • [8] Hepatocellular Carcinoma Does the Background Liver With or Without Cirrhosis Matter?
    Jain, Anisha
    Mazer, Benjamin
    Deng, Yanhong
    Ciarleglio, Maria
    Jain, Dhanpat
    Taddei, Tamar
    Zhang, Xuchen
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 157 (02) : 305 - 313
  • [9] Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: A case-control study of 213 hepatocellular carcinoma patients from India
    Kumar, Manoj
    Kumar, Rakesh
    Hissar, Syed S.
    Saraswat, Manoj Kumar
    Sharma, Barjesh Chander
    Sakhuja, Puja
    Sarin, Shiv Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (07) : 1104 - 1111
  • [10] Peri-operative outcomes for pancreatoduodenectomy in India: a multi-centric study
    Shukla, Parul J.
    Barreto, Savio G.
    Bedi, M. M. S.
    Bheerappa, N.
    Chaudhary, Adarsh
    Gandhi, M. D.
    Jacob, M.
    Jesvanth, S.
    Kannan, D. G.
    Kapoor, Vinay K.
    Kumar, A.
    Maudar, K. K.
    Ramesh, Hariharan
    Sastry, R. A.
    Saxena, Rajan
    Sewkani, Ajit
    Sharma, S.
    Shrikhande, Shailesh V.
    Singh, A.
    Singh, Rajneesh K.
    Surendran, R.
    Varshney, Subodh
    Verma, V.
    Vimalraj, V.
    HPB, 2009, 11 (08) : 638 - 644